
Overview
Mark Albertini, MD, is a UW Health medical oncologist (cancer doctor) specializing in melanoma skin cancers. He’s also a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health.Dr. Albertini treats patients with cancers at risk of spreading, and advanced cancers that aren’t responding to standard treatment. He helps patients understand their condition and treatment options, including immunotherapy and other advances in melanoma care. Dr. Albertini sees patients before and after surgery and throughout their cancer journey.Understanding cancer’s emotional impact, Dr. Albertini encourages patients to replace uncertainty with hope based on knowing they’re getting the best care. He collaborates with other medical professionals to help patients benefit from the latest treatments and insights so they can live longer and better-quality lives.Dr. Albertini is a nationally known melanoma researcher who leads treatment, research studies and clinical trials at the University of Wisconsin Carbone Cancer Center. He studies ways to get the immune system to fight cancer. He also leads clinical trials to study therapies for patients with treatment-resistant cancers.Outside of work, Dr. Albertini enjoys biking, cross-country skiing and spending time with his family.The most rewarding part of caring for my patients is coming up with treatments that can help patients with advanced melanoma.
Dr. Albertini is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Melanoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Neuroendocrine Tumor.
Dr. Albertini is board certified in Internal Medicine and Medical Oncology. He is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 10 clinical trials. Dr. Albertini is currently accepting new patients.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- HMO
- POS
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- EPO
- HMO
- INDEMNITY
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
600 Highland Ave, Madison, WI 53792
4621 Eastpark Blvd, Madison, WI 53718
600 Highland Ave, Madison, WI 53792
600 Highland Ave, Madison, WI 53792
Additional Areas of Focus
Dr. Albertini has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
UW Health|Carbone Cancer Center Hematology Clinic
Natalie Callander, MD, is a UW Health hematologist specializing in blood disorders and multiple myeloma blood cancer. She’s also a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health.Dr. Callander treats multiple myeloma and complications such as anemia, bone fractures and infections. She leads the multiple myeloma clinical program at the UW Health|Carbone Cancer Center. Dr. Callander’s specialties include advanced stem cell transplantation, during which patients may receive their own transplanted cells or compatible donor cells.Understanding that cancer care can feel overwhelming, Dr. Callander takes time to listen to her patients and guide them through treatment options and care. She reassures patients and shares resources and medical advances that can greatly improve their treatment results and quality of life.Dr. Callander and her UW Health colleagues are at the forefront of research for multiple myeloma. Her research focuses on autologous (self) stem cell transplantation and new cellular and medical therapies for multiple myeloma. She invites her patients to participate in clinical studies that can benefit them personally while also contributing to improved cancer care.Outside of work, Dr. Callander enjoys cooking and spending time with her family.It’s been incredibly gratifying to take care of patients that I met 20 years ago who are doing great. Dr. Callander is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Callander is board certified in Hematology, Internal Medicine, and Medical Oncology. Dr. Callander is currently accepting new patients.
UW Health|Carbone Cancer Center Hematology Clinic
Vaishalee Kenkre, MD, is a UW Health hematologist and an associate professor in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health.Dr. Kenkre treats patients with all types of lymphoma, a blood cancer, including Hodgkin lymphoma and non-Hodgkin lymphoma. As part of the cellular therapy group team, she provides care for people who need a bone marrow transplant or CAR T-cell therapy.Dr. Kenkre finds the field of hematology to be a fulfilling specialty because she can help people through their treatment. Though the care she provides is very clinical, she believes compassion is key. She enjoys getting to know each of her patients in order to tailor their care to best meet their needs and preferences.In addition to her clinical and teaching roles, Dr. Kenkre is involved with clinical research trials for people with lymphoma.In her free time, Dr. Kenkre enjoys traveling and spending time with her children.Even though the medical part of what I do is very clinical, getting to know each person’s experiences and expectations allows me to tailor their care to fit their unique needs. Dr. Kenkre is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Kenkre is board certified in Hematology and Medical Oncology. Dr. Kenkre is currently accepting new patients.
UW Health|Carbone Cancer Center Medical Oncology Clinic
Dustin Deming, MD, is a UW Health medical oncologist with a clinical emphasis on gastrointestinal cancers, including colon, rectal, anal, esophageal, liver and pancreatic cancers. He is also a professor at the University of Wisconsin School of Medicine and Public Health in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care. Dr. Deming is known for his commitment to delivering evidence‑based, compassionate care to patients facing complex cancer diagnoses.Dr. Deming’s research program focuses on developing improved treatments for specific subtypes of colon cancer and other gastrointestinal malignancies. His work centers on understanding how tumor‑specific genetic mutations influence treatment response, with the goal of creating personalized therapy regimens for individual patients. By using advanced animal models, his research helps bridge the gap between laboratory discoveries and clinical application.In addition to his translational research, Dr. Deming’s laboratory has developed innovative three‑dimensional cell culture techniques to advance clinical cancer research. He also leads efforts to identify new and improved biomarkers to better predict disease behavior and treatment outcomes. Through his combined roles as a clinician, researcher, and educator, Dr. Deming contributes to advancing precision oncology and improving care for patients with gastrointestinal cancers. Dr. Deming is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, PIK3CA-Related Overgrowth Spectrum, Familial Colorectal Cancer, Anal Cancer, and Liver Embolization. Dr. Deming is board certified in Internal Medicine and Medical Oncology. Dr. Deming is currently accepting new patients.
UW Health|Carbone Cancer Center Medical Oncology Clinic
Glenn Liu, MD, is a UW Health medical oncologist and a professor in the Department of Medicine, Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health.Dr. Liu specializes in treating advanced genitourinary cancers. These include cancers affecting the urinary and male reproductive organs such as the prostate, bladder, kidneys and testicles. Dr. Liu cares for patients who are both newly diagnosed and those with recurrent (returning) cancer.Dr. Liu’s care philosophy is based on shared decision-making. He believes that listening to patients is essential. He listens to their concerns and educates them about their condition and treatment options. He is excited about the many new discoveries happening now in the field of medical oncology and offers personalized care to best meet his patients’ needs.In addition to his clinical and teaching roles, Dr. Liu researches new cancer therapies. This includes testing new treatments, improving decision-making processes and enhancing how health care teams interact with patients.Outside of work, Dr. Liu enjoys playing tennis, hiking and fishing.Being able to answer questions and provide support and help is very rewarding. Dr. Liu is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, and Orchiectomy. Dr. Liu is board certified in Medical Oncology. Dr. Liu is currently accepting new patients.
UW Health|Carbone Cancer Center Medical Oncology Clinic
Dr. Lang is a professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health, Madison, WI. He specializes in genitourinary cancer and medical oncology. Dr. Lang is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Prostatectomy, and Nephrectomy. Dr. Lang is board certified in Internal Medicine and Medical Oncology. Dr. Lang is currently accepting new patients.
UW Health|Carbone Cancer Center Medical Oncology Clinic
Douglas McNeel, MD, PhD, is a UW Health medical oncologist and a professor in the Division of Hematology, Medical Oncology and Palliative Care at the University of Wisconsin School of Medicine and Public Health, Department of Medicine. He cares for people with prostate, bladder, kidney and testicular cancer using the most advanced treatments available.Dr. McNeel sees himself as a partner, working together with patients and their families to come up with the best treatment plan using the latest therapy options. He’s excited about the progress in cancer care and the treatments now available that didn’t exist just a decade ago.A medical research opportunity in college led Dr. McNeel toward his career as a doctor. He was drawn to the possibility of conducting research that could have a positive impact on the care he provides. He currently leads studies on immune-based treatments, like vaccines, for prostate cancer and is the director of Solid Tumor Immunology Research at the UW Carbone Cancer Center.Dr. McNeel is a musician and spends his free time playing the pipe organ.My hope for each patient is that they find either a treatment or an outcome that works best for them and works best for their family. Long term, we want to use the ‘cure’ word more often for patients with cancer. And so that's my ultimate long-term goal. Dr. Mcneel is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, and Adult Soft Tissue Sarcoma. Dr. Mcneel is board certified in Medical Oncology. Dr. Mcneel is currently accepting new patients.
Frequently Asked Questions about Dr. Mark Albertini
How do I make an appointment with Dr. Mark Albertini?
You can book an appointment with Dr. Mark Albertini by calling their office at 608-915-0100. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mark Albertini a top-rated expert for Melanoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark Albertini is classified as an Elite expert for Melanoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mark Albertini specialize in?
While Dr. Mark Albertini is a Hematology, they have specific expertise in Melanoma, Melanoma of the Eye, and Metastatic Uveal Melanoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Mark Albertini participate in research or clinical trials?
Yes. Dr. Mark Albertini has published 46 articles and abstracts on conditions like Melanoma. You can view a list of Dr. Mark Albertini's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mark Albertini accept my insurance?
Dr. Mark Albertini accepts most major insurance plans, including Anthem BCBS and Aspirus Arise Health. We recommend calling the office directly at 608-915-0100 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- MelanomaDr. Albertini isElite. Learn about Melanoma.
- Advanced
- Melanoma of the EyeDr. Albertini isAdvanced. Learn about Melanoma of the Eye.
- Metastatic Uveal MelanomaDr. Albertini isAdvanced. Learn about Metastatic Uveal Melanoma.
- Experienced
- Anal CancerDr. Albertini isExperienced. Learn about Anal Cancer.
- GliomaDr. Albertini isExperienced. Learn about Glioma.
- Hairy Cell Leukemia (HCL)Dr. Albertini isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Metastatic Brain TumorDr. Albertini isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Albertini isExperienced. Learn about Neuroendocrine Tumor.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)Dr. Albertini isExperienced. Learn about Paroxysmal Nocturnal Hemoglobinuria (PNH).
- Posterior Fossa TumorDr. Albertini isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Albertini isExperienced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Uveal MelanomaDr. Albertini isExperienced. Learn about Uveal Melanoma.
- Vulvar CancerDr. Albertini isExperienced. Learn about Vulvar Cancer.





